Consider increasing when Side effects are mild and controlled Appetite suppression is incomplete most of the week Weight trend has been flat for 34 consecutive weeks Consider holding when Nausea, reflux, constipation, or fatigue is lingering You are already getting full faster and eating less Weight is still trending down, even slowly We share the journey with the patient
An epidemiologic study performed in South Korea showed that from September 2019 to December 2022, 5,100 patients were admitted to the ICU with a diagnosis of sepsis, of whom 3,177 (62.3%) developed S-AKI
In terms of tolerability, tirzepatide generally causes fewer gastrointestinal side effects, making it a better option for those sensitive to nausea, while Semaglutide GLP-1 may cause mild to moderate gastrointestinal issues like nausea and diarrhea, which usually subside over time
But from real GLP-1 experience, the hardest part is often everything between the shots: food noise, nausea, hydration, constipation, protein, social eating, weight stalls, progress photos, and staying consistent without making the journey feel like a second job
